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Abstract
One thousand hospitals were surveyed on a new measure of health-care personnel influenza 
vaccination for the 2012–2013 influenza season. Facilities found it easier to collect data on 
employees than nonemployees; larger facilities reported more challenges than smaller facilities. 
Barriers may decrease over time as facilities become accustomed to the measure.
In 2007, the Joint Commission began requiring hospitals and long-term care facilities to 
provide annual influenza vaccinations to healthcare personnel (HCP) and to evaluate 
vaccination coverage as a condition of accreditation.1 US hospitals have historically lacked 
uniformity with how HCP influenza vaccination coverage is measured.2 In May 2012, the 
National Quality Forum endorsed the Centers for Disease Control and Prevention’s (CDC) 
HCP Influenza Vaccination Measure (NQF 0431), hereafter referred to as “HCP measure.” 
More than 4,000 acute care hospitals were required to report on the HCP measure starting 
January 1, 2013, as a part of the Centers for Medicare & Medicaid Services’ Hospital 
Inpatient Quality Reporting Program.
The HCP measure requires facilities to collect influenza vaccination data for 3 HCP 
categories: employees, licensed independent practitioners (LIPs), and adult students/trainees 
and volunteers. For the 2012–2013 influenza season, facilities were required to collect data 
on the number of vaccinations received inside or outside the facility, medical 
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contraindications, vaccination declinations, and unknown vaccination status, along with the 
total number of HCP in each category for those working in the facility for 30 days or more 
from October 1 through March 31. The data were reported through the CDC’s National 
Healthcare Safety Network (NHSN), a national Internet-based surveillance system for 
healthcare-associated infections.3
METHODS
In August 2013, an online questionnaire was used to survey staff collecting data for NHSN 
at nonfederal acute care hospitals. More than 4,000 facilities were identified through the 
NHSN enrollment database; 3,315 facilities were included in the final sampling frame 
stratified by the 4 US Census Bureau Regions and 3 bed-size groups (≤100 beds, 101–300 
beds, >300 beds).4 A simple random sample of 1,000 facilities was selected using the 
probability-proportional-to-size method without replacement for each stratum. Data 
collectors at sampled facilities were invited by email to participate in the survey and 
nonresponders were reminded to complete this via email and telephone. Data were analyzed 
in SAS, version 9.3 (SAS Institute) and an electronic spreadsheet (Excel; Microsoft). 
Statistical significance was set at P =.05.
RESULTS
Of the 1,000 facilities surveyed, 68% (n =680) responded; 277 facilities (41%) had 100 or 
fewer beds, 248 (37%) had 101–300 beds, and 150 (22%) had more than 300 beds. There 
were 427 facilities (63%) with policies recommending, but not requiring HCP to receive 
vaccination; 205 facilities (30%) reported mandatory influenza vaccination policies for all 
HCP. Of responding facilities, most had at least 2 years of experience collecting HCP 
influenza vaccination data; 508 facilities (75%) made changes to their data collection 
procedures to facilitate NHSN reporting. Most facilities used paper records to collect HCP 
vaccination status.
Most facilities had a mechanism for counting HCP; however, of the major data collection 
barriers, HCP not routinely present in the facility was most commonly reported (Table 1). 
Facilities with more than 300 beds were more likely to report major barriers to counting 
HCP not routinely in or rotating through the facility than smaller facilities, along with 
having no way to count LIPs or adult students/trainees.
Collecting vaccination status data for employees was not a barrier for 396 facilities (68%), 
but 106 (18%) reported it as a major barrier for LIPs and 83 (15%) for adult students/
trainees (Table 2). Facilities reported having barriers to reporting vaccination status due to 
other entities not providing data on HCP; in particular, 156 facilities (26%) reported this as 
major barrier for LIPs. Facilities with more than 300 beds were more likely to report major 
barriers to collecting vaccination status for LIPs and volunteers than smaller facilities.
Respondents perceived the accuracy of vaccination status data to be very or somewhat 
accurate for employees (n =639; 99%), LIPs (n =569; 89%), adult students/trainees (n =526; 
83%), and adult volunteers (n =577; 90%). Facilities reporting major barriers to collecting 
data for LIPs, adult students/trainees, or adult volunteers were significantly more likely to 
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have perceived their data to be inaccurate for these HCP categories compared with facilities 
reporting no major barriers.
Almost half of respondents reported that a benefit of collecting data for NHSN was that it 
helped communicate vaccination coverage to HCP (n = 333; 49%); more than 50% of 
facilities (n =401) responded that NHSN provides data for other reporting requirements, 
44% (n =299) reported that it helped increase vaccination promotion efforts, 42% (n =286) 
reported that it helped improve the HCP tracking system, and 13% (n =88) reported no 
perceived benefit.
DISCUSSION
Although facilities reported data collection challenges for the HCP measure, in general, 
facilities found it easier to collect data on employees and adult volunteers, and smaller 
facilities reported fewer challenges. Factors such as size of facility, data collection methods, 
and facilities’ previous experience collecting data may all contribute to the ease of reporting 
vaccination coverage to NHSN and perceived accuracy of collected data.
Many facilities reported not having mechanisms for counting specific HCP groups; in 
particular, facilities had difficulty collecting data on HCP who do not routinely work in the 
facility. It may be difficult for data collectors to report on nonemployees because they do not 
have access to information owned by other entities, and the reporting facility may have no 
contractual obligation to report the data, which is consistent with our qualitative evaluation 
findings.4 Our findings complement other studies reporting that most organizations can 
collect data for only a subset of HCP, have difficulty gathering the HCP vaccination status 
for vaccinations received outside a facility, and have trouble assessing the number of 
nonemployees.5,6
Most facilities in our evaluation used paper-based data collection mechanisms rather than 
electronic systems. Electronic data collection systems can increase the ease of collecting 
vaccination data and can provide additional benefits beyond collecting influenza vaccination 
coverage data: reports have found that these systems offer the flexibility of data use for other 
activities,7,8 such as providing the ability to monitor vaccination coverage in real-time by 
location or occupation.9
Although most facilities in our evaluation had previous experience collecting data, they still 
faced a number of barriers. NHSN reporting requirements may be different than the 
information facilities have historically collected and more extensive than what facilities’ 
current data collection systems allow. A study from 2006 found that most hospitals 
measured influenza vaccination coverage for employees, but fewer hospitals measured 
coverage for nonemployee HCP or included coverage of vaccine refusal or contraindication.
2
Limitations of this evaluation include not being able to determine how respondents defined 
data accuracy. In addition, the survey was designed to assess the experiences of data 
collectors in acute care hospitals; therefore, the results may not reflect the experience of 
reporting data to NHSN for other types of facilities.
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The National Quality Forum endorsed the HCP measure with the expectation that it would 
drive improvement in data collection. A universal standard for HCP influenza vaccination 
coverage could help ease data collection and reporting for facilities; barriers to NHSN 
reporting may decrease as facilities develop processes and systems for collecting the 
necessary data. The measure has been adjusted since the first season of data collection to 
require facilities to submit data for any HCP working in the facility for at least 1 day; this 
change may result in a decrease in reported barriers to data collection because most facilities 
felt such a change would maintain or improve the accuracy of collected data. It is important 
to continue monitoring implementation of the HCP measure to ensure it is producing high-
quality data that can be used to improve influenza vaccination coverage among HCP in the 
United States.
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